[Two cases of ocular damage associated with proton pump inhibitors].
Kohno
M
M
First Department of Internal Medicine, Matsue City Hospital.
Yamada
M
M
Okumura
T
T
Hori
K
K
Hoshino
U
U
Yoshimura
T
T
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D001562:Benzimidazoles / Q000009:adverse effects*; D005260:Female; D006801:Humans; D064747:Lansoprazole; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000009:adverse effects / Q000031:analogs & derivatives*; D054328:Proton Pump Inhibitors; D064750:Rabeprazole; D014786:Vision Disorders / Q000139:chemically induced*
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D001562:Benzimidazoles; D054328:Proton Pump Inhibitors; D064747:Lansoprazole; D064750:Rabeprazole; D009853:Omeprazole